{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:10Z","timestamp":1789020430748,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infection of susceptible livestock species, including domestic cattle and American bison, with ovine gammaherpesvirus-2 (OvHV-2), a gammaherpesvirus in the genus Macavirus, can result in an often-fatal disease known as sheep-associated malignant catarrhal fever (SA-MCF). Prevention of SA-MCF via vaccination is a key goal to support livestock producers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed the safety and immunogenicity of a viral-vectored vaccine candidate consisting of a non-pathogenic recombinant alcelaphine gammaherpesvirus-1 expressing the OvHV-2 glycoprotein B (rAlHV-1\/OvHV-2gB). The vaccine, formulated with an oil-in-water adjuvant, was administered intramuscularly to cattle using a prime-plus-two-boosters regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Immunized animals did not develop MCF following rAlHV-1\/OvHV-2gB inoculation. The vaccine virus did not establish persistent infection, and no viral shedding was detected after any immunization. Minor and transient adverse reactions associated with the adjuvant use were observed in some animals. Immunization with rAlHV-1\/OvHV-2gB significantly altered the proportions of monocytes, T- and B- cells and induced the production of IFN-\u03b3, CCL4, and CXCL10 in blood. Following\n                      <jats:italic>in vitro<\/jats:italic>\n                      stimulation with rAlHV-1\/OvHV-2gB, peripheral blood mononuclear cells from immunized animals exhibited proliferation of CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      cells, along with production of both pro- and anti-inflammatory cytokines and chemokines. OvHV-2 gB-specific antibodies were present in both blood and nasal secretions, with neutralizing antibodies detected only in blood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the need for further optimization of vaccine formulation and delivery, the rAlHV-1\/OvHV-2gB vaccine elicited robust immune responses, supporting further evaluation of its protective efficacy in vaccine-challenge trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1895085","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:33:38Z","timestamp":1789018418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and immunogenicity of a malignant catarrhal fever vaccine candidate expressing ovine gammaherpesvirus-2 glycoprotein B in cattle"],"prefix":"10.3389","volume":"17","author":[{"given":"Daniela D.","family":"Mor\u00e9","sequence":"first","affiliation":[{"name":"Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture","place":["Pullman, WA, United States"]},{"name":"Department of Veterinary Microbiology and Pathology, Washington State University","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi S.","family":"Taus","sequence":"additional","affiliation":[{"name":"Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture","place":["Pullman, WA, United States"]},{"name":"Department of Veterinary Microbiology and Pathology, Washington State University","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Baker","sequence":"additional","affiliation":[{"name":"Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Herndon","sequence":"additional","affiliation":[{"name":"Department of Veterinary Microbiology and Pathology, Washington State University","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginaldo G.","family":"Bastos","sequence":"additional","affiliation":[{"name":"Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture","place":["Pullman, WA, United States"]},{"name":"Department of Veterinary Microbiology and Pathology, Washington State University","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Dewals","sequence":"additional","affiliation":[{"name":"Department of Infectious and Parasitic Diseases, University of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vanderplasschen","sequence":"additional","affiliation":[{"name":"Department of Infectious and Parasitic Diseases, University of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina W.","family":"Cunha","sequence":"additional","affiliation":[{"name":"Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture","place":["Pullman, WA, United States"]},{"name":"Department of Veterinary Microbiology and Pathology, Washington State University","place":["Pullman, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/0300985813520435","article-title":"The pathology of Malignant catarrhal fever, with an emphasis on ovine herpesvirus 2","volume":"51","author":"O'Toole","year":"2014","journal-title":"Vet Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.140.20.519","article-title":"Chronic and recovered cases of sheep-associated Malignant catarrhal fever in cattle","volume":"140","author":"O'Toole","year":"1997","journal-title":"Vet Rec"},{"key":"B3","article-title":"Long distance spread of Malignant catarrhal fever virus from feedlot lambs to ranch bison","volume":"49","author":"Li","year":"2008","journal-title":"Can Vet J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0034-5288(03)00043-2","article-title":"Genome re-arrangements associated with loss of pathogenicity of the gamma-herpesvirus alcelaphine herpesvirus-1","volume":"75","author":"Wright","year":"2003","journal-title":"Res Vet Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.056","article-title":"An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced Malignant catarrhal fever","volume":"26","author":"Haig","year":"2008","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1297-9716-43-51","article-title":"Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced Malignant catarrhal fever","volume":"43","author":"Russell","year":"2012","journal-title":"Vet Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2016.09.019","article-title":"The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen\u00ae and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 Malignant catarrhal fever induced by experimental virus challenge","volume":"195","author":"Lankester","year":"2016","journal-title":"Veterinary Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.040","article-title":"A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated Malignant catarrhal fever in cattle","volume":"37","author":"Cook","year":"2019","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126587","article-title":"Field vaccination of locally-owned cattle against Malignant catarrhal fever under environmentally challenging conditions in Tanzania","volume":"45","author":"Bainbridge","year":"2025","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145073","article-title":"Cross-reactivity of neutralizing antibodies among Malignant catarrhal fever viruses","volume":"10","author":"Taus","year":"2015","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0166-0934(01)00419-0","article-title":"Potential of bovine herpesvirus 4 as a gene delivery vector","volume":"101","author":"Donofrio","year":"2002","journal-title":"J Virological Methods"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216531110","article-title":"An essential role for g-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattle","volume":"110","author":"Palmeira","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020090","article-title":"OvHV-2 glycoprotein B delivered by a recombinant BoHV-4 is immunogenic and induces partial protection against sheep-associated Malignant catarrhal fever in a rabbit model","volume":"9","author":"Shringi","year":"2021","journal-title":"Vaccines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122156","article-title":"A vaccine targeting ovine herpesvirus 2 glycoprotein B protects against sheep-associated Malignant catarrhal fever","volume":"10","author":"Cunha","year":"2022","journal-title":"Vaccines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/pathogens13030219","article-title":"Ovine herpesvirus 2 glycoprotein B complementation restores infectivity to a bovine herpesvirus 4 gB-null mutant","volume":"13","author":"Mor\u00e9","year":"2024","journal-title":"Pathogens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00108-16","article-title":"Replacement of glycoprotein B in alcelaphine herpesvirus 1 by its ovine herpesvirus 2 homolog: implications in vaccine development for sheep-associated Malignant catarrhal fever","volume":"1","author":"Cunha","year":"2016","journal-title":"mSphere"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02454-16","article-title":"Ovine herpesvirus 2 glycoproteins B, H, and L are sufficient for, and viral glycoprotein Ov8 can enhance, cell-cell membrane fusion","volume":"91","author":"AlHajri","year":"2017","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.05.021","article-title":"A real-time PCR assay for measuring alcelaphine herpesvirus-1 DNA","volume":"129","author":"Traul","year":"2005","journal-title":"J Virological Methods"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.11.026","article-title":"Antibodies to ovine herpesvirus 2 glycoproteins decrease virus infectivity and prevent Malignant catarrhal fever in rabbits","volume":"175","author":"Cunha","year":"2015","journal-title":"Veterinary Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404536121","article-title":"Unraveling clonal CD8 T cell expansion and identification of essential factors in \u03b3-herpesvirus-induced lymphomagenesis","volume":"121","author":"Gong","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1297-9716-45-59","article-title":"The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated Malignant catarrhal fever in cattle","volume":"45","author":"Parameswaran","year":"2014","journal-title":"Veterianry Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100090","article-title":"Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant","volume":"8","author":"Russell","year":"2021","journal-title":"Vaccine: X"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.02.028","article-title":"Special features of \u03b3\u03b4 T cells in ruminants","volume":"134","author":"Baldwin","year":"2021","journal-title":"Mol Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071502","article-title":"Phenotypic and functional heterogeneity of bovine blood monocytes","volume":"8","author":"Hussen","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2010.03.023","article-title":"CD8+\/perforin+\/WC1- [gamma][delta] T cells, not CD8+ [alpha][beta] T cells, infiltrate vasculitis lesions of American bison (Bison bison) with experimental sheep-associated Malignant catarrhal fever","volume":"136","author":"Nelson","year":"2010","journal-title":"Veterinary Immunol Immunopathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001627","article-title":"Malignant catarrhal fever induced by alcelaphine herpesvirus 1 is associated with proliferation of CD8 T cells supporting a latent infection","volume":"3","author":"Dewals","year":"2008","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1297-9716-42-95","article-title":"Malignant catarrhal fever induced by Alcelaphine herpesvirus 1 is characterized by an expansion of activated CD3+CD8+CD4- T cells expressing a cytotoxic phenotype in both lymphoid and non-lymphoid tissues","volume":"42","author":"Dewals","year":"2011","journal-title":"Vet Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01463-08","article-title":"The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens","volume":"82","author":"Gredmark-Russ","year":"2008","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/ijms19061642","article-title":"VEGF upregulation in viral infections and its possible therapeutic implications","volume":"19","author":"Alkharsah","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: Cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895085\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:33:39Z","timestamp":1789018419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895085\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1895085"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1895085","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1895085"}}